rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-2-6
|
pubmed:abstractText |
Complete remission of B-precursor acute lymphoblastic leukemia (ALL) has traditionally been defined as the near absence of lymphoblasts in a light-microscopical examination of stained bone marrow smears, but a patient in remission may still harbor up to 10(10) leukemia cells. We investigated whether there is a relation between the outcome of treatment and submicroscopic evidence of residual disease.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
336
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
317-23
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9011783-Bone Marrow,
pubmed-meshheading:9011783-Child,
pubmed-meshheading:9011783-Clone Cells,
pubmed-meshheading:9011783-DNA, Neoplasm,
pubmed-meshheading:9011783-Disease-Free Survival,
pubmed-meshheading:9011783-Humans,
pubmed-meshheading:9011783-Neoplasm, Residual,
pubmed-meshheading:9011783-Neoplastic Stem Cells,
pubmed-meshheading:9011783-Polymerase Chain Reaction,
pubmed-meshheading:9011783-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:9011783-Prospective Studies,
pubmed-meshheading:9011783-Recurrence,
pubmed-meshheading:9011783-Remission Induction,
pubmed-meshheading:9011783-Tumor Stem Cell Assay
|
pubmed:year |
1997
|
pubmed:articleTitle |
Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
|
pubmed:affiliation |
Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|